Background/Objectives: It has been reported that alcohol stimulates appetite. We aimed to establish the association between leptin, as a major food intake regulating factor, and alcohol intake in patients with chronic manifest coronary artery or cerebrovascular disease. Subjects/Methods: A cross-sectional study of 820 subjects after acute coronary syndrome, coronary revascularization or after first ischemic stroke (the Czech part of EUROASPIRE III surveys). Leptin concentrations were evaluated among predefined categories of reported weekly alcohol intake: abstainers, light drinkers (up to 2 drinks weekly, 1-44 g of pure alcohol), mild regular drinkers (3-14 drinks weekly, 45-308 g) and moderate or heavy drinkers (more than 15 drinks, X309 g of alcohol). Results: Leptin showed a clear negative trend among the alcohol intake categories. Mild regular drinkers showed significantly lower leptin levels (9.3(8.2) ng/ml) compared with abstainers (18.7(18.7) ng/ml, Po0.0001) and light occasional drinkers (14.2(17.8) ng/ml, P ¼ 0.00064). The negative association between leptin and alcohol intake as a dependent variable remained significant even after adjustment for potential confounders in multiple linear regression analysis (P ¼ 0.00032). Conclusions: Drinking of small amounts of alcohol was, in our setting, associated with decreased serum leptin concentration, with a possible benefit in terms of cardiovascular risk.
Introduction
Leptin is a polypeptide hormone, secreted mainly from adipocytes (and from gastric mucosa and placenta as well) as a product of the 'obese' (ob) gene and is primarily biologically active in the hypothalamus (Zhang et al., 1994; Schwartz et al., 1996) . Endogenous leptin is known as a major regulatory factor of appetite and food intake. Administration of leptin reduces food consumption and body weight and increases energy expenditure (Pelleymounter et al., 1995; Schwartz et al., 1996) , whereas, paradoxically, obese subjects showed a high expression of leptin-mRNA levels in the adipose tissue and increased concentrations of leptin in systemic circulation (Considine et al., 1996) , probably because of a phenomenon known as 'leptin resistance'. The possibility that increased leptin levels might be relevant to many aspects of cardiac and vascular regulation has been raised, suggesting that leptin promotes atherothrombotic processes involved in the pathophysiology of vascular diseases (Bouloumie et al., 1999; Donahue et al., 1999; Soderberg et al., 1999; Bodary et al., 2002; Singhal et al., 2002; Bullo et al., 2003) .
Alcohol has been recognized for centuries as an appetizer, but the interaction between alcohol and leptin has not been well understood and infrequent studies have shown equivocal results. In this study, we aimed to establish the relationship between alcohol intake and serum leptin concentration in the pattern of chronic nonexcessive mild drinking.
Materials and methods
This study represents a cross-sectional analysis. The study population consisted of pooled samples from two surveys of patients with stabilized manifest coronary heart disease (CHD) or after first ischemic stroke. CHD patients were examined in 2006-2007 as the Czech part of the EUROASPIRE III survey. Details of the sample selection and standard protocol of the examination have been described elsewhere . Briefly, patients aged p80 years, hospitalized for any of the following discharge diagnoses, were retrospectively identified from hospital records: first coronary bypass graft, first percutaneous transluminal coronary angioplasty and acute myocardial infarction or ischemia. Recruitment of patients started with most recent hospital records and proceeded backward until the required sample of 600 subjects was obtained. Patients were interviewed 6-24 months after the index event (coronary event or revascularization) Stroke patients were examined in 2007 as the Czech part of the EUROASPIRE III-stroke survey, and again, details of the sample selection and standard protocol of the examination have been described elsewhere . A total of 507 consecutive patients aged p80 years hospitalized for first ischemic stroke were selected and the responders were interviewed 6-36 months after the event occurred. Both surveys were conducted in the same two centers of the Czech Republic: University Hospital Pilsen and Cardio-Centre of Institute of Clinical and Experimental Medicine in Prague.
The standard protocol of the EUROASPIRE survey was followed, as described elsewhere (Kotseva et al., 2009) . Briefly, patients were interviewed at least 6 months after their index event. Information on personal and demographic characteristics, personal and family history of coronary heart disease, lifestyle and pharmacotherapy was obtained. The following standardized examinations were carried out: Height and weight were measured in light indoor clothes without shoes using SECA 220 scales (SECA GmbH, Hamburg, Germany) and measuring sticks. Waist circumference was measured using a tape measure. Blood pressure was measured twice in the sitting position on the right arm using a standard mercury sphygmomanometer. Carbon monoxide in the patients' breath was measured using a Smokerlyser (model EC 50, Bedfont Scientific, UK). Venous blood samples were drawn after at least 12 h of overnight fast. All laboratory examinations were carried out in series from aliquots stored at À801C using commercial kits, and included the estimation of total and high-density lipoprotein (HDL) cholesterol, using an ARCHITECT c800 analyzer (Abbott Laboratories, Wiesbaden, Germany) and DOT diagnostics kits (DOT Diagnostics sro., Prague, Czech Republic), and triglyceride and glucose (GLU) levels using the same analyzer and Abbott Laboratories standard kits. Glycohemoglobin (HbA1c) was estimated by ionex liquid chromatography using the G7 analyzer (TOSOH Inc., Toyama, Japan), whereas serum leptin and insulin levels were measured using commercial radioimmunoassay kits (Millipore-Linco Research, St Charles, MO, USA). The patient's weekly alcohol intake was assessed by 1-week follow-back (a questionnaire used for INTERSALT study (Elliott and Stamler, 1988) and the subjects were asked whether it was their typical alcohol intake (if not, correction was made using alcohol intake data of a typical week). The total weekly alcohol intake was calculated as follows: one beer 121 (half liter) 22 g, one beer 101 20.5 g, one glass of wine (two deciliters) 22 g, one large glass of spirit (half of deciliter) 20 g and one small glass of spirit (0.2 of deciliter) 8 g of pure alcohol. The whole sample of patients was categorized by the reported weekly alcohol intake into abstainers, light irregular drinkers (1-44 g of pure alcohol weekly), mild regular drinkers (45-308 g) and moderate or heavy drinkers (X 309 g).
Statistical analysis was performed using the software STATISTICA 8 (StatSoft Inc, Tulsa, OK, USA). All data were stored under the provisions of the Czech data protection act. The whole study was carried out under Good Clinical Practice regulations, the study protocol was approved by the local ethical committee and all study participants signed the informed consent form.
Results
A total of 820 vascular patients, 479 with manifest coronary heart disease and 341 after first ischemic stroke were analyzed in this study. The baseline characteristics of pooled data and separately for CHD and stroke patients are given in Table 1 . Patients after stroke were significantly older and were more often female, compared with CHD patients. Stroke patients showed, on an average, a higher heart rate, and total LDL, HDL cholesterol and serum leptin levels, but a lower waist -to-hip ratio and reported weekly alcohol intake. Stroke patients were also less often treated with betablockers and statins, and more often with thiazide diuretics.
The association between alcohol intake categories and a large set of risk factors or characteristics is given in Table 2 ; the statistical differences were tested between mild regular drinkers (category III) against all the other three categories. A comparison of mild regular drinkers with abstainers showed that the latter were older, more often female, had higher total cholesterol, HDL, LDL and HbA1c levels, but were less often treated with betablockers and statins.
Serum leptin concentrations significantly decreased with increasing alcohol intake among the defined categories (Table 2 and Figure 1 ). The Spearman's coefficient for correlation between leptin and weekly alcohol intake was À0.32 (Po0.0001). The independency of association between leptin and alcohol intake was tested by multiple linear regression (Table 3) . Using weekly alcohol intake as a dependent continuous variable, leptin concentration was a significantly negative independent variable in the regression, even after adjustment for conventional risk factors as potential confounders. Moreover, age, gender, body mass index and waist circumference were identified as significant predictors in this setting. The second regression model (not shown in the table section) consisted of alcohol intake as a dependent variable, as well as age, gender, leptin and concomitant treatments (that is, betablockers, angiotensin-converting enzyme inhibitors or angiotensin II blockers, thiazide diuretics, statins and antidiabetics). Any concomitant treatment did not enter this regression as a significant confounding factor. Table 4 expressed the leptin concentration by alcohol intake categories among prespecified subgroups of risk factors and characteristics. The majority of these factors themselves influenced leptin levels significantly (first column); however, the overall negative trend in leptin concentration among alcohol intake categories remained statistically significant in all subgroups. The effect of alcohol intake on leptin levels was significantly more pronounced in obese subjects than in nonobese subjects and more in females than in males (last column, Table 4 ).
Discussion
In our study, we found a clear, highly statistically significant and independent negative association between serum leptin concentrations and reported weekly alcohol intake. The association remained statistically significant even after adjustment for potential confounders, namely, body constitution, GLU metabolism and current smoking. Our study sample consisted of middle aged and elderly patients, with stable manifest vascular disease and rather nonexcessive drinking habits. The whole intake of alcohol (if any) resulted generally from regular drinking of small amounts of alcohol; nobody tended to binge drink. The maximal individual reported alcohol intake was 792 g of alcohol weekly that is, 36 alcoholic drinks (beers) weekly (or ca five daily). The stroke patient showed significantly lower alcohol consumption than did cardiac patients, probably because of higher age and seriousness of comorbidities. The effect of alcohol on leptin as a major appetiteregulating factor is not well understood and remains to be elucidated in detail. Alcohol is often taken before meals as an aperitif. It has been reported (Hetherington et al., 2001 ) that an alcoholic beverage taken before the meal had a stimulatory effect on food intake and increased energy intake by 30%. Chronic alcoholics showed low leptin concentrations (Santolaria et al., 2003) , probably because of frequent chronic malnutrition, leading to a reduced fat tissue mass (as primary organ of leptin synthesis). Leptin also positively correlates with alcohol-craving in patients admitted for detoxification treatment (Hillemacher et al., 2007) . The interaction between alcohol and leptin on a background of only nonexcessive chronic alcohol drinking is probably more complex, and relative sparse studies of this association showed equivocal results. One interventional study (Djurovic et al., 2007) reported that a 3-week regular intake of one glass of red wine per day increased leptin levels by about 17%, but only in females. A recent general population-based cross-sectional study (Marques-Vidal et al., 2009) did not find any significant association between alcohol intake and leptin levels, confirming a similar conclusion of two other reports (Lagiou et al., 1999; Pischon et al., 2005) . On the contrary, an interventional study (Röjdmark et al., 2001 ) observed in healthy subjects that acute intake of ethanol (0.45 g/kg, 3 doses, 2 h apart) inhibited leptin secretion. A similar study (Otaka et al., 2007) reported that the serum leptin level significantly decreased in rats 3-6 h after alcohol ingestion, whereas gastric levels remained unaffected and leptin concentration in fat tissue significantly increased. This study suggested that decreased serum leptin after alcohol administration might be due to the suppression of leptin secretion from adipose tissue into systemic circulation. Our study is in line with these two reports, confirming its conclusions in the subjects with chronic, nonexcessive drinking on mild alcohol amounts. The proportion of 'more-than-mild' drinkers was in our sample rather low (only 5.1% of sample), and this is probably the reason why the difference in leptin concentration between mild and heavy drinkers did not reach statistical significance (in spite of the clear negative trend).
We may only speculate about the pathophysiological mechanism of the observed alcohol-leptin interaction. Leptin expression is modulated by several factors, including glucocorticoids, insulin and serotonin, which stimulate leptin release, and catecholamines, which inhibit it (Donahoo et al., 1997; Fruhbeck et al., 1998) . A plausible hypothesis is that alcohol suppressed the release of leptin from adipose tissue into systemic circulation by an increased release of catecholamines. Several indirect mechanisms are also feasible. It is evident that insulin stimulates leptin secretion (Malmström et al., 1996) and that alcohol drinkers show lower insulinemia and GLU concentrations (Šimon et al., 1988; Röjdmark et al., 2001) . However, in our study, abstainers did not show any differences in insulin, GLU or homeostasis model assessment index, despite their leptin concentration being almost double of that in mild regular drinkers. This is in accordance with the above-mentioned study, showing no changes in insulin in connection with acute alcohol intake (and leptin decrease as well) (Röjdmark, 1979) .
As beer was the most common alcoholic beverage, we may also speculate that the observed negative trend in leptin among increased alcohol intake also depends on the type of alcoholic beverage consumed. In mice, Xantohumol, a compound from beer hops (Humulus lupulus), lowered (besides plasma GLU and triglycerides) the mass of adipose tissue and increased levels of plasma adiponectin (Nozawa, 2005) , both with very close metabolic relation to leptin concentration. The type of alcoholic beverage in prevalence could also be the source of equivocal results of existing alcohol-leptin association studies. Unfortunately, we cannot test this hypothesis, as the sample of patients drinking beverages other than beer is very limited. The crucial question remains whether markedly lower leptin concentration, observed in mild regular drinkers, represents any benefit in terms of individual cardiovascular risk. It is well evident that drinking of mild amounts of alcohol was associated with lower cardiovascular mortality (Keil et al., 1997) in the general population, but whether the same holds true for cardiovascular patients and whether leptin has any role in this causality is not clear. In our setting, subjects with a regular drinking habit showed slightly lower body mass index than abstainers. This is a paradox because the majority of alcohol intake was covered by beer (a rather high-caloric beverage). On the other hand, we found a significant positive association of alcohol intake with waist circumference (Table 3 ). This pattern, that is, substandard BMI, although it increased waist circumference ('beer belly' with slim leg), was typically associated with alcohol consumption in several epidemiological studies (Filipovskỳ et al., 1993) . Mild regular alcohol drinkers also showed significantly lower HbA1c levels than abstainers, which could also be hypothetically accounted for by low leptin concentrations. In contrast, in our setting we did not observe the usual positive association between alcohol and HDL cholesterol. The possible explanation is the frequent statin treatment (about 70%) 'masking' this probably only very slight HDL increase. The more favorable lipid profile of mild drinkers could also be probably explained better by more frequent lipid-lowering treatment than by the effect of alcohol itself. Several clinical and experimental studies suggested that leptin promotes atherosclerosis and thrombosis, and reported positive associations with established vascular risk factors, such as lipids, blood pressure (Donahue et al., 1999) , impaired fibrinolysis or prothrombotic status (Soderberg et al., 1999) , endothelial dysfunction or increased vessel wall stiffness (Bouloumie et al., 1999; Singhal et al., 2002) , and inflammation (Bullo et al., 2003) . Particular attention is given to a possible role of leptin in the pathophysiology of type II diabetes and prediabetic disorders (Leyva et al., 1998; Zimmet et al., 1998) . Studies dealing with leptin and incident vascular diseases are relatively sparse and heterogeneous. A systematic review of seven prospective studies (Sattar et al., 2009) reported that the adjusted risk ratio of CHD among subjects with leptin in the top tertile was 1.44; however, it did not reach statistical significance. The authors suggest that the association between leptin and CHD risk is largely dependent on BMI. Thus, the causality of leptin in vascular disease etiology remains to be elucidated in detail. Our study has several limitations; namely, the estimated ethanol intake is based on reported amounts of alcohol drinks and only during a 1-week time frame (moreover, we asked whether the reported alcohol intake is the typical one); however, the majority of epidemiological studies probably had a similar limitation. Nobody showed an excessive increase in the gama-glutaryl transferase level. Thus, we can presume that the reported alcohol intake is generally correct. Our study sample consisted of a very specific population of middle-aged or elderly patients with stable manifest vascular diseases, and the whole distribution of alcohol intake markedly differed from that of the general population. The usual recommendations for secondary prevention of vascular diseases is to tolerate (but not to encourage) the voluntary intake of mild amounts of alcohol (up to two drinks daily), and ca 95% of our subjects were compliant with this rule. Therefore, in contrast to usual standards, the category of light occasional drinkers was taken into account separately. These subjects reported an alcohol intake up to 2 drinks weekly (usually during weekend) and we wanted to test whether such a low intake may also have a role in their risk profile. Indeed, their average leptin concentration was between abstainers and mild drinkers.
In conclusion, in our study we found that leptin concentration showed a clear negative trend among alcohol intake categories in vascular disease patients. Whether rather low levels of leptin in subjects with regular mild intake of alcohol represents any benefit in terms of their cardiovascular risk remains to be solved.
